Tdap Recommendations

CDC has published Tdap recommendations for both adolescents and adults.

Please see Recommendation tabs at left for more information.

 

Recommendations for Adolescents

CDC recommends replacing your patients' next Td with Tdap*

Information on this page is general information about pertussis.

Approval of Boostrix® (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) for use in preventing tetanus, diphtheria, and pertussis was based on immune response data. BOOSTRIX has not been proven to have a positive impact on the potential consequences or outcomes of tetanus, diphtheria, and pertussis. To determine whether BOOSTRIX is right for your patients, please see the complete Prescribing Information.